| Heather Kiesel, | |
|
9 Lacrue Ave, Suite 210, Glen Mills, PA 19342-1062 | |
| (800) 578-7906 | |
| (800) 878-5497 |
| Full Name | Heather Kiesel |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 9 Lacrue Ave, Glen Mills, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194954057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL007939 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Kiesel, Po Box 7, Concordville, PA 19331-0007 Ph: () - | Heather Kiesel, 9 Lacrue Ave, Suite 210, Glen Mills, PA 19342-1062 Ph: (800) 578-7906 |
News Archive
Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health found that the orally administered experimental drug EIDD-2801 halts SARS-CoV-2 replication and prevents infection of human cells in a new in vivo lab model containing human lung tissue.
Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of cloud-based healthcare compliance solutions, today announced the outcome of a new study that shows significant, measurable efficiency gains when using the automated messaging capabilities of its U-Sleep compliance management solution.
A novel minimally invasive surgery for young children living with a difficult-to-treat progressive form of scoliosis, known as juvenile idiopathic scoliosis, may eliminate the need for spinal fusion later in adolescence, according to new research by surgeons from Children's Mercy Hospitals and Clinics in Kansas City, Mo. The study was presented at the American Academy of Pediatrics National Conference and Exhibition in San Francisco.
Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection) for the treatment of women with relapsed ovarian cancer.
› Verified 7 days ago
Haley L Kypers, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 300 Franklin Dr, Glen Mills, PA 19342 Phone: 610-936-6514 | |
Carly Gross, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 | |
Stephanie D. Phelps, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 | |
Tanya Srouji, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 | |
Amy Hartford-jacobs, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Maris Grove Way, Glen Mills, PA 19342 Phone: 610-387-4622 | |
Lynn Gabos, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8 Thomas Speakman Dr, Glen Mills, PA 19342 Phone: 610-613-1498 | |
Goldy Levy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 |